General
Preferred name
SODIUM OXYBATE
Synonyms
GHB ()
Catabate ()
WY-3478 ()
NSC-84223 ()
Oxybate sodium ()
Sodium oxybutyrate ()
Xyrem ()
.gamma.-hydroxybutyrate sodium salt ()
Lumryz ()
Sodium oxybat ()
GHB (sodium salt) ()
GHB (sodium salt) (exempt preparation) ()
P&D ID
PD002526
CAS
502-85-2
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Anesthesia, Adjunct To
First approval
2002
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
INDICATION
For the treatment of cataplexy and excessive daytime sleepiness (EDS) associated with narcolepsy.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
7
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
Ki Database
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
16
Molecular Weight
126.03
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
0
Aromatic Ring Count
0
cLogP
-4.49
TPSA
60.36
Fraction CSP3
0.75
Chiral centers
0.0
Largest ring
0.0
QED
0.39
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
